Royalty Pharma
RPRX
#987
Rank
HK$145.32 B
Marketcap
HK$253.05
Share price
1.27%
Change (1 day)
17.05%
Change (1 year)

EPS for Royalty Pharma (RPRX)

EPS in 2023 (TTM): HK$4.35

According to Royalty Pharma's latest financial reports the company's current EPS (TTM) is HK$4.27. In 2022 the company made an earnings per share (EPS) of HK$0.78 a decrease over its 2021 EPS that were of HK$11.64.

EPS history for Royalty Pharma from 2019 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$4.35460.35%
2022HK$0.78-93.33%
2021HK$11.64-1.33%
2020HK$11.80-77.07%
2019HK$51.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$3.65-185.45%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$23.07 440.40%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$42.14 887.14%๐Ÿ‡บ๐Ÿ‡ธ USA